• Resize Text
    • Small Text
    • Medium Text
    • Large Text
    • Connect
Malignant Disease & Immunosuppression
Malignant Disease & Immunosuppression

Tamoxifen Rosemont Oral Solution

Tamoxifen is a medicine used to treat breast cancer.

Tamoxifen Oral Solution is indicated for the following:

The treatment of breast cancer

The primary prevention of breast cancer in women at moderate or high risk (see SmPC)

Icon respresenting a network

Summary of Product Characteristics

Read this summary of product characteristics for further information about Tamoxifen Oral Solution. Click below to navigate to the EMC.

More info
Icon respresenting a person

Patient Information Leaflet

Read this patient information leaflet about Tamoxifen Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.

More info
Malignant Disease & Immunosuppression

Tamoxifen Rosemont Oral Solution

Rosemont Tamoxifen 10mg 150ml
Click here for Audio Version
Flavour Liquorice & aniseed
Storage Conditions Do not store above 25°C. Do not refrigerate or freeze. Store in the original package in order to protect from light.
Sucrose Free
Shelf Life (Closed Bottle/Open Bottle) 24 months / 3 months
PIP Code 265-3053
EAN Code 50-16119-16489-7
Sodium Levels None
Ethanol Concentration 750mg/5ml


Adverse Drug Events

Information about adverse event reporting can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Rosemont Pharmaceuticals Ltd on 0113 244 1400

Rosemont Pharmaceuticals - World Map icon

Contact us

For further product information and pricing please use the form below and a member of the team will be in touch

[contact-form-7 id="275" title="Contact form 1" html_class="two-col-contact-form"]

Stay updated via our App


A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.

Rosemont app on a mobile device

Malignant Disease & Immunosuppression

Rosemont Tamoxifen 10mg 150ml

Tamoxifen Rosemont Oral Solution